Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ETV7 antibody (AA 134-218)

The Rabbit Polyclonal anti-ETV7 antibody has been validated for WB, ELISA and IHC. It is suitable to detect ETV7 in samples from Human.
Catalog No. ABIN7616813

Quick Overview for ETV7 antibody (AA 134-218) (ABIN7616813)

Target

See all ETV7 Antibodies
ETV7 (Ets Variant 7 (ETV7))

Reactivity

  • 47
  • 12
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Human

Host

  • 43
  • 4
Rabbit

Clonality

  • 45
  • 2
Polyclonal

Conjugate

  • 22
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ETV7 antibody is un-conjugated

Application

  • 36
  • 13
  • 13
  • 10
  • 6
  • 3
  • 3
  • 2
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Binding Specificity

    • 15
    • 6
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 134-218

    Purpose

    Etv7 Polyclonal Antibody

    Characteristics

    The Etv7 Polyclonal Antibody (Species: Human) has been validated for the following applications: ELISA, WB, IHC.

    Purification

    Protein G Purified

    Purity

    >95%

    Immunogen

    Recombinant Human Transcription Factor Etv7 Protein

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Preservative: 0.03 % Proclin 300, Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    ETV7 (Ets Variant 7 (ETV7))

    Alternative Name

    ETV7

    UniProt

    Q9Y603
You are here:
Chat with us!